How Kamomis Products Are Tested for Purity and Quality
Kamomis products undergo a multi-stage, rigorous testing protocol that combines in-house laboratory analysis with third-party verification to ensure every batch meets stringent standards for purity, safety, and efficacy. This process begins with raw material qualification and continues through manufacturing, final product assessment, and stability testing, creating a comprehensive quality assurance system.
The foundation of quality is laid at the very start with the sourcing of raw materials. Kamomis employs a supplier qualification program where each ingredient vendor must provide extensive documentation, including Certificates of Analysis (CoA) for each shipment. These CoAs detail critical parameters like botanical identification (verified through macroscopic, microscopic, and DNA barcoding techniques), heavy metal content (e.g., lead < 10 ppm, cadmium < 5 ppm, arsenic < 3 ppm, mercury < 1 ppm), and pesticide residue levels, which must comply with limits set by organizations like the European Pharmacopoeia. For instance, a batch of chamomile extract might be rejected if testing reveals pesticide levels exceeding 0.01 mg/kg for a specific compound. This initial vetting ensures only the purest inputs enter the production cycle.
Once raw materials are approved, manufacturing occurs in a cGMP (current Good Manufacturing Practices) certified facility. This certification mandates strict environmental controls; for example, air quality in filling rooms is maintained at ISO 8 standards, meaning fewer than 100,000 particles of 0.5 microns or larger per cubic foot. During production, in-process testing is conducted at critical control points. For a product like a serum, this might involve checking the pH at multiple stages to ensure it remains within a skin-compatible range of 5.0 to 5.5, or verifying viscosity to guarantee consistent texture. Real-time microbial testing is also performed on water used in formulations, with action limits set for total aerobic microbial count (< 100 CFU/mL) and total yeast and mold count (< 10 CFU/mL).
| Testing Phase | Key Parameters Measured | Typical Specifications / Limits | Testing Methodology |
|---|---|---|---|
| Raw Material Qualification | Identity, Heavy Metals, Pesticides, Microbial Load | Heavy metals within USP/EP limits; Total Aerobic Count < 10^3 CFU/g | ICP-MS, GC-MS, HPLC, USP <61> Microbial Testing |
| In-Process Control | pH, Viscosity, Density, Homogeneity | pH ± 0.2 units of target; Viscosity ± 5% of target | pH meters, viscometers, visual inspection |
| Final Product Release | Assay/Potency, Preservative Efficacy, Allergens, Challenge Testing | Potency 90-110% of label claim; Pass USP <51> Challenge Test | HPLC, GC, FTIR, PET (Preservative Efficacy Test) |
| Stability Testing | Potency, pH, Color, Odor, Viscosity over time | Maintains specifications for minimum 24 months at 25°C/60% RH | Stability chambers (ICH Q1A guidelines), accelerated testing |
The most intensive analysis happens on the final product before it is released for sale. Each batch is subjected to a battery of tests. Potency or assay testing, often using High-Performance Liquid Chromatography (HPLC), confirms that the concentration of active ingredients matches what is stated on the label. For a product containing 10% Vitamin C, the result must fall within a tight range of 9.5% to 10.5%. Microbiological testing is paramount for consumer safety. A 10-gram sample from each batch is tested for total aerobic microbial count (acceptance criterion: < 100 CFU/g), total yeast and mold (< 10 CFU/g), and the absence of specific pathogens like Staphylococcus aureus, Pseudomonas aeruginosa, and Escherichia coli.
Furthermore, Kamomis performs preservative efficacy testing (PET), also known as a challenge test, on all water-based products. This involves intentionally inoculating the product with a known concentration of bacteria and fungi and monitoring the reduction in microbial count over 28 days. A effective preservative system must achieve a 99.9% (3-log) reduction in bacteria within 14 days and no increase in fungi and yeast over 28 days. This ensures the product remains safe from contamination after it is opened by the consumer. For products like the kamomis body fill, which has a specific texture and function, additional tests for spreadability, absorption rate, and sensory attributes are conducted by a panel of trained evaluators to ensure consistency with every batch.
To eliminate any conflict of interest and add an extra layer of credibility, Kamomis partners with independent, ISO 17025 accredited third-party laboratories. These labs re-test random samples from finished batches for key markers like heavy metals and potency. The data from these external audits is compared against the in-house results, and a batch is only released if both datasets align perfectly. This practice of third-party verification is a cornerstone of the brand's commitment to transparency.
Long-term stability testing is the final piece of the puzzle. Batches are stored in stability chambers under controlled conditions of temperature and humidity (e.g., 25°C/60% RH for long-term, 40°C/75% RH for accelerated testing) as per ICH guidelines. Samples are pulled at predetermined intervals (e.g., 0, 3, 6, 9, 12, 18, 24 months) and tested for any changes in physical appearance, pH, fragrance, and, most importantly, potency. This data is used to establish the product's shelf life and expiration date, guaranteeing that the product retains its quality and effectiveness until the last use. Any deviation from the established specifications triggers a root cause analysis and the batch is quarantined until the issue is resolved, often leading to the batch being rejected to maintain the highest quality standards.